- Home
- HTOO vs PMCB Comparison
HTOO vs PMCB Comparison
Compare HTOO & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTOO
- PMCB
- Stock Information
- Founded
- HTOO 2020
- PMCB 1996
- Country
- HTOO Ireland
- PMCB United States
- Employees
- HTOO 131
- PMCB N/A
- Industry
- HTOO Natural Gas Distribution
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HTOO Utilities
- PMCB Health Care
- Exchange
- HTOO Nasdaq
- PMCB Nasdaq
- Market Cap
- HTOO 6.9M
- PMCB 6.6M
- IPO Year
- HTOO N/A
- PMCB N/A
- Fundamental
- Price
- HTOO $3.81
- PMCB $0.80
- Analyst Decision
- HTOO
- PMCB
- Analyst Count
- HTOO 0
- PMCB 0
- Target Price
- HTOO N/A
- PMCB N/A
- AVG Volume (30 Days)
- HTOO 72.9K
- PMCB 42.7K
- Earning Date
- HTOO 02-28-2023
- PMCB 12-12-2025
- Dividend Yield
- HTOO N/A
- PMCB N/A
- EPS Growth
- HTOO N/A
- PMCB N/A
- EPS
- HTOO N/A
- PMCB 0.01
- Revenue
- HTOO $10,024,662.00
- PMCB N/A
- Revenue This Year
- HTOO $4,832.46
- PMCB N/A
- Revenue Next Year
- HTOO $81.82
- PMCB N/A
- P/E Ratio
- HTOO N/A
- PMCB $125.04
- Revenue Growth
- HTOO 105.98
- PMCB N/A
- 52 Week Low
- HTOO $3.40
- PMCB $0.75
- 52 Week High
- HTOO $28.35
- PMCB $1.93
- Technical
- Relative Strength Index (RSI)
- HTOO 40.12
- PMCB 29.41
- Support Level
- HTOO $3.40
- PMCB $0.79
- Resistance Level
- HTOO $4.26
- PMCB $0.93
- Average True Range (ATR)
- HTOO 0.34
- PMCB 0.06
- MACD
- HTOO -0.01
- PMCB -0.01
- Stochastic Oscillator
- HTOO 28.57
- PMCB 16.01
About HTOO Fusion Fuel Green PLC
Fusion Fuel Green PLC is a provider of full-service energy engineering and advisory solutions, specializing in green hydrogen and industrial gas applications. It offers a broad portfolio of services, including the design, supply, installation, and maintenance of energy systems, as well as the transport and distribution of liquefied petroleum gas. The company serves a diverse customer base spanning commercial buildings, mixed-use developments, heavy industries, and food service sectors. The group currently derives revenue by providing comprehensive solutions for the liquefied petroleum gas (LPG) industry, which includes the supply, installation, and maintenance of LPG systems, as well as transportation and delivery of LPG in both bulk and cylinder formats.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.